Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 36.82 CNY -3.18% Market Closed
Market Cap: 34B CNY
Have any thoughts about
Livzon Pharmaceutical Group Inc?
Write Note

Livzon Pharmaceutical Group Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Livzon Pharmaceutical Group Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Livzon Pharmaceutical Group Inc
SZSE:000513
Total Current Liabilities
ÂĄ9.7B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
14%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Current Liabilities
ÂĄ6.9B
CAGR 3-Years
37%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Current Liabilities
ÂĄ2.5B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
27%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Current Liabilities
ÂĄ4.8B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Current Liabilities
ÂĄ13.8B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Current Liabilities
ÂĄ1.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Livzon Pharmaceutical Group Inc
Glance View

Market Cap
34B CNY
Industry
Pharmaceuticals

Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 8,580 full-time employees. LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The firm's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The firm distributes its products in the domestic market and to overseas markets.

Intrinsic Value
48.61 CNY
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Livzon Pharmaceutical Group Inc's Total Current Liabilities?
Total Current Liabilities
9.7B CNY

Based on the financial report for Jun 30, 2024, Livzon Pharmaceutical Group Inc's Total Current Liabilities amounts to 9.7B CNY.

What is Livzon Pharmaceutical Group Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
14%

Over the last year, the Total Current Liabilities growth was 18%. The average annual Total Current Liabilities growth rates for Livzon Pharmaceutical Group Inc have been 14% over the past three years , 14% over the past five years , and 14% over the past ten years .

Back to Top